Skip to main content
Thor Medical ASA logo

Thor Medical ASA — Investor Relations & Filings

Ticker · NANOV ISIN · NO0010597883 LEI · 5967007LIEEXZXG6DK30 OL Manufacturing
Open in API
Filings indexed 106 across all filing types
Latest filing 2026-02-26 Interim / Quarterly Rep…
Country NO Norway
Listing OL NANOV

About Thor Medical ASA

https://www.thormedical.com/

Thor Medical ASA is a producer and supplier of alpha-particle emitters for cancer therapy. The company specializes in manufacturing isotopes, such as Thorium-228, by separating decay products from naturally occurring Thorium-232. This is achieved through a proprietary production technology that offers high efficiency, cost-competitiveness, and superior environmental friendliness. The company provides these critical alpha-emitters to partners developing next-generation targeted alpha therapies for precision oncology.

Recent filings

Filing Released Lang Actions
Thor Medical ASA: Second-Half and Full-Year 2025 Results - AlphaOne on Track, Backed by Strong Commercial Momentum - Attachment: Thor Medical 2H and FY 2025 report_PDF.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report 2H and FY 2025' and contains detailed financial statements, including a Profit and Loss statement, balance sheet data, and cash flow summaries for the specified period. It provides a comprehensive review of operations, commercial momentum, and financial position, which aligns with the definition of an Interim/Quarterly Report (IR). It is not an announcement of a report, as it contains the actual financial data and analysis. FY 2025
2026-02-26 English
Thor Medical ASA: Second-Half and Full-Year 2025 Results - AlphaOne on Track, Backed by Strong Commercial Momentum - Attachment: Download announcement as PDF.pdf
Report Publication Announcement Classification · 95% confidence The document is an announcement from Thor Medical ASA regarding their 'Second-Half and Full-Year 2025 Results'. While it provides a summary of financial highlights and operational progress, it explicitly lists the actual 'Thor Medical 2H and FY 2025 report' as an attachment at the end of the text. Following the 'Menu vs Meal' rule, this document serves as an announcement of the report's publication rather than the comprehensive financial report itself. Therefore, it is classified as a Report Publication Announcement (RPA). FY 2025
2026-02-26 English
Thor Medical ASA: Second-Half and Full-Year 2025 Results - AlphaOne on Track, Backed by Strong Commercial Momentum
Report Publication Announcement Classification · 95% confidence The document is an announcement from Thor Medical ASA regarding their 'Second-Half and Full-Year 2025 Results'. While it provides a summary of financial highlights and operational updates, it explicitly includes links to separate PDF attachments for the actual '2H and FY 2025 report' and the 'Interim 2H and FY 2025 Presentation'. According to the 'Menu vs Meal' rule, a short document that announces the release of a report and provides links to it is classified as a Report Publication Announcement (RPA). FY 2025
2026-02-26 English
Thor Medical ASA: Invitation to Presentation of Second-Half and Full-Year 2025 Results - Attachment: Download announcement as PDF.pdf
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 5,000 characters) inviting investors and media to a presentation of upcoming financial results. It explicitly states that the results will be published at a future date and time, and provides details for the event. Per the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself, and therefore qualifies as a Report Publication Announcement (RPA).
2026-02-18 English
Thor Medical ASA: Invitation to Presentation of Second-Half and Full-Year 2025 Results
Report Publication Announcement Classification · 100% confidence The document is an invitation to a presentation of financial results, not the results themselves. It explicitly states that the report will be published on a future date (February 26, 2026). Following the 'Menu vs Meal' rule, this is an announcement regarding the release of a report, which classifies it as a Report Publication Announcement (RPA).
2026-02-18 English
Thor Medical ASA - New share capital registered - Attachment: Download announcement as PDF.pdf
Share Issue/Capital Change Classification · 100% confidence The document announces the registration of a new share capital increase following an incentive program. It explicitly mentions the new share capital amount and the total number of shares. This falls under the category of share capital changes or new share issues.
2026-01-23 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.